| mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
7e-05 |
| mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.2 |
0.0001 |
| mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0006 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
| mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
-0.83 |
0.0009 |